{"id":59153,"date":"2024-04-04T19:05:47","date_gmt":"2024-04-04T17:05:47","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\/"},"modified":"2024-04-04T19:05:47","modified_gmt":"2024-04-04T17:05:47","slug":"xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\/","title":{"rendered":"XCath CEO Eduardo Fonseca Spotlights AI in Endovascular Robotics at SLICE Next Frontiers Conference"},"content":{"rendered":"
\n

\nSession addressed current and future clinical applications for XCath\u2019s technology<\/i><\/p>\n

HOUSTON–(BUSINESS WIRE)–XCath<\/a>, an early-stage medical device company dedicated to expanding endovascular treatment modalities through its robotic systems and steerable guidewires, presented at the annual SLICE Next Frontiers Conference<\/a> hosted by Dr. Vincent Costalat and Master and Fellow<\/a>. The event, which took place from April 3-4 and was broadcasted live from the Montpellier Centre Hospitalier Universitaire in France, was designed to address the endovascular treatment of cerebral pathologies.<\/p>\n

<\/a>
<\/a><\/p>\n

\nXCath\u2019s chief executive officer, Eduardo Fonseca, gave a presentation titled, \u201cThe Future of Endovascular Interventions.\u201d The exhibition focused on the process behind endovascular robotic procedures and XCath\u2019s efforts to develop devices that could potentially deliver practical clinical commercial value beyond the lab. Drs. Vitor Pereira and Adnan Siddiqui were also present and provided a very positive view on robotics, agreeing that it is a burgeoning field and that the future of neurovascular interventions will include the technology.<\/p>\n

\n\u201cThe SLICE Next Frontiers conference convenes thought leaders from across the neuro space and is a key opportunity to learn about current innovations and where we\u2019re going next,\u201d said Fonseca. \u201cIn conversations that took place at the event about robotics, AI and telerobotics there was a lot of enthusiasm about how these technologies can enhance patient care. These objectives are all top of mind at XCath, and we look forward to being part of the future of neurovascular interventions.\u201d<\/p>\n

\nFor more information about the SLICE Next Frontiers Conference, visit https:\/\/masterandfellow.com\/slice\/nf<\/a>. To learn more about XCath, visit https:\/\/www.xcath.com\/<\/a><\/p>\n

\nAbout XCath<\/b><\/p>\n

\nFounded in 2017, XCath is a dynamic startup at the cutting edge of revolutionary medical robotics, nanorobotics and materials science. XCath develops next-generation endovascular robotic systems and steerable guidewires to treat life-threatening conditions like cerebrovascular disorders. With strategically located campuses in Houston, Texas \u2013 home to the world’s largest medical center \u2013 and Pangyo, South Korea, often referred to as the Silicon Valley of Korea, XCath is committed to bringing its innovative solutions to patients around the world.<\/p>\n

\nRegulatory Disclaimer: steerable guidewires and endovascular robotic systems are under development. Not available for sale or use worldwide.<\/p>\n

Contacts<\/b> <\/p>\n

\nMatter Health for XCath
\n
Dan Ventresca
\n
T: 617-874-5488
\n
xcath@matternow.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Session addressed current and future clinical applications for XCath\u2019s technology HOUSTON–(BUSINESS WIRE)–XCath, an early-stage medical device company dedicated to expanding endovascular treatment modalities through its robotic systems and steerable guidewires, presented at the annual SLICE Next Frontiers Conference hosted by Dr. Vincent Costalat and Master and Fellow. The event, which took place from April 3-4 … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-59153","6":"format-standard","7":"category-industry"},"yoast_head":"\nXCath CEO Eduardo Fonseca Spotlights AI in Endovascular Robotics at SLICE Next Frontiers Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"XCath CEO Eduardo Fonseca Spotlights AI in Endovascular Robotics at SLICE Next Frontiers Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Session addressed current and future clinical applications for XCath\u2019s technology HOUSTON–(BUSINESS WIRE)–XCath, an early-stage medical device company dedicated to expanding endovascular treatment modalities through its robotic systems and steerable guidewires, presented at the annual SLICE Next Frontiers Conference hosted by Dr. Vincent Costalat and Master and Fellow. The event, which took place from April 3-4 ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-04T17:05:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240404194526\/en\/2089597\/22\/XCath_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"XCath CEO Eduardo Fonseca Spotlights AI in Endovascular Robotics at SLICE Next Frontiers Conference\",\"datePublished\":\"2024-04-04T17:05:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\\\/\"},\"wordCount\":387,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240404194526\\\/en\\\/2089597\\\/22\\\/XCath_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\\\/\",\"name\":\"XCath CEO Eduardo Fonseca Spotlights AI in Endovascular Robotics at SLICE Next Frontiers Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240404194526\\\/en\\\/2089597\\\/22\\\/XCath_Logo.jpg\",\"datePublished\":\"2024-04-04T17:05:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240404194526\\\/en\\\/2089597\\\/22\\\/XCath_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240404194526\\\/en\\\/2089597\\\/22\\\/XCath_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"XCath CEO Eduardo Fonseca Spotlights AI in Endovascular Robotics at SLICE Next Frontiers Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"XCath CEO Eduardo Fonseca Spotlights AI in Endovascular Robotics at SLICE Next Frontiers Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\/","og_locale":"en_US","og_type":"article","og_title":"XCath CEO Eduardo Fonseca Spotlights AI in Endovascular Robotics at SLICE Next Frontiers Conference - Pharma Trend","og_description":"Session addressed current and future clinical applications for XCath\u2019s technology HOUSTON–(BUSINESS WIRE)–XCath, an early-stage medical device company dedicated to expanding endovascular treatment modalities through its robotic systems and steerable guidewires, presented at the annual SLICE Next Frontiers Conference hosted by Dr. Vincent Costalat and Master and Fellow. The event, which took place from April 3-4 ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\/","og_site_name":"Pharma Trend","article_published_time":"2024-04-04T17:05:47+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240404194526\/en\/2089597\/22\/XCath_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"XCath CEO Eduardo Fonseca Spotlights AI in Endovascular Robotics at SLICE Next Frontiers Conference","datePublished":"2024-04-04T17:05:47+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\/"},"wordCount":387,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240404194526\/en\/2089597\/22\/XCath_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\/","url":"https:\/\/pharma-trend.com\/en\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\/","name":"XCath CEO Eduardo Fonseca Spotlights AI in Endovascular Robotics at SLICE Next Frontiers Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240404194526\/en\/2089597\/22\/XCath_Logo.jpg","datePublished":"2024-04-04T17:05:47+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240404194526\/en\/2089597\/22\/XCath_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240404194526\/en\/2089597\/22\/XCath_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/xcath-ceo-eduardo-fonseca-spotlights-ai-in-endovascular-robotics-at-slice-next-frontiers-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"XCath CEO Eduardo Fonseca Spotlights AI in Endovascular Robotics at SLICE Next Frontiers Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59153","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=59153"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59153\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=59153"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=59153"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=59153"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}